Chilton Capital Management LLC Sells 33 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Chilton Capital Management LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 75,552 shares of the healthcare conglomerate’s stock after selling 33 shares during the period. UnitedHealth Group accounts for approximately 2.0% of Chilton Capital Management LLC’s holdings, making the stock its 7th biggest position. Chilton Capital Management LLC’s holdings in UnitedHealth Group were worth $39,776,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Richelieu Gestion SA bought a new position in shares of UnitedHealth Group in the fourth quarter valued at $26,000. Robbins Farley acquired a new position in shares of UnitedHealth Group in the third quarter worth $25,000. CGC Financial Services LLC increased its position in UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares during the last quarter. NewSquare Capital LLC raised its stake in shares of UnitedHealth Group by 340.0% in the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 51 shares in the last quarter. Finally, Strategic Investment Solutions Inc. IL bought a new position in UnitedHealth Group in the 1st quarter worth $35,000. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the topic of several research analyst reports. Oppenheimer restated an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Barclays initiated coverage on UnitedHealth Group in a research report on Wednesday, March 6th. They set an “overweight” rating and a $551.00 target price for the company. Royal Bank of Canada reiterated an “outperform” rating and issued a $596.00 target price on shares of UnitedHealth Group in a research note on Thursday, February 29th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Finally, Bank of America restated a “buy” rating and set a $675.00 target price on shares of UnitedHealth Group in a research report on Thursday, March 7th. One research analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $579.33.

Insider Activity

In related news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a filing with the SEC, which is accessible through this link. In other news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE UNH traded up $1.60 on Friday, reaching $494.70. 3,820,008 shares of the stock were exchanged, compared to its average volume of 4,274,309. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.62. The company’s 50-day simple moving average is $503.10 and its two-hundred day simple moving average is $518.61. UnitedHealth Group Incorporated has a one year low of $445.68 and a one year high of $554.70. The firm has a market capitalization of $456.08 billion, a PE ratio of 20.75, a PEG ratio of 1.34 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The business had revenue of $94.43 billion for the quarter, compared to analysts’ expectations of $92.13 billion. During the same period in the prior year, the firm earned $5.34 EPS. The company’s revenue for the quarter was up 14.1% on a year-over-year basis. Analysts expect that UnitedHealth Group Incorporated will post 27.82 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s payout ratio is 31.54%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.